Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia. Issue 3 (16th January 2018)

• Record Type: Journal Article
• Authors: Yishake, Mumingjiang; Yasen, Miersalijiang; Jiang, Libo; Liu, Wangmi; Xing, Rong; Chen, Qian; Lin, Hong; Dong, Jian
• Is Part Of: Journal of orthopaedic research. Volume 36:Issue 3(2018)
• Page Start: 937
• Page End: 944
• Publication Date: 2018-01-16
• Subjects: osteoporosis -- ovariectomized rat -- spinal fusion -- teriparatide -- zoledronic acid; Orthopedics -- Periodicals; Musculoskeletal system -- Periodicals; 616.7
• DOI: 10.1002/jor.23682
• Languages: English
• ISSNs: 0736-0266

Abstract

ABSTRACT: There has been no study regarding the effect of a combination of teriparatide (TPTD) and zoledronic acid (ZA) on vertebral fusion. In this study, we investigate the effect of single and combined TPTD and ZA treatment on lumbar vertebral fusion in aged ovariectomized (OVX) rats. Sixty two‐month‐old female Sprague‐Dawley rats were ovariectomized and underwent bilateral L4–L5 posterolateral intertransverse fusion after 10 months. The OVX rats received vehicle (control) treatment, or ZA (100 µg/kg, once), or TPTD (60 µg/kg/2 d for 42 d), or ZA + TPTD until they were euthanized at 6 weeks following lumbar vertebral fusion. The lumbar spine was harvested. Bone mineral density (BMD), bone fusion, bone volume (BV), and bone formation rate (BFR)were analyzed by dual‐energy X‐ray absorptiometry (DXA), radiography, micro‐computed tomography, and histomorphometry. Compared with vehicle (control) treatment, ZA and TPTD monotherapy increased bone volume (BV) at fusion site, and ZA + TPTD combined therapy had an additive effect. Treatment with TPTD and ZA + TPTD increased the bone fusion rate when compared with the control group. ZA monotherapy did not alter the rate of bone fusion. The TPTD and ZA + TPTD treatment groups had increased mineral apposition rate (MAR), mineralizing surfaces/bone surface ((MS/BS), and BFR/BS compared with the OVX group. Our experiment confirm that the monotherapy with TPTD and combination therapy with ZA + TPTD in an OVX rat model of osteopenia following lumbar vertebral fusion surgery increased bone fusion mass and bone fusion rate, and ZA + TPTD combined therapy had an additive effect on bone fusion mass. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:937–944, 2018. Abstract : In this study, we investigate the effect of single and combined teriparatide (TPTD) and zoledronic acid (ZA) treatment on lumbar vertebral fusion in aged ovariectomized (OVX) rats. Our experiment confirm that the monotherapy with TPTD and combination therapy with ZA+TPTD in an OVX rat model of osteopenia following lumbar vertebral fusion surgery increased bone fusion mass and bone fusion rate, and ZA+TPTD combined therapy had an additive effect on bone fusion mass.